Cargando…

Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors

Diffuse-type gastric carcinomas (DGC) exhibit more aggressive progression and poorer prognosis than intestinal-type and other gastric carcinomas. To identify potential therapeutic targets, we examined protein tyrosine phosphorylation in a panel of DGC and other gastric cancer cell lines. Protein tyr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamaguchi, Hideki, Takanashi, Miho, Yoshida, Nachi, Ito, Yuumi, Kamata, Reiko, Fukami, Kiyoko, Yanagihara, Kazuyoshi, Sakai, Ryuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317844/ https://www.ncbi.nlm.nih.gov/pubmed/24612061 http://dx.doi.org/10.1111/cas.12387

Ejemplares similares

Stromal Fibroblasts Mediate Extracellular Matrix Remodeling and Invasion of Scirrhous Gastric Carcinoma Cells
por: Yamaguchi, Hideki, et al.
Publicado: (2014)

PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification
por: Nagamura, Yuko, et al.
Publicado: (2021)

Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation
por: Yamaguchi, Hideki, et al.
Publicado: (2011)

Elevated METTL9 is associated with peritoneal dissemination in human scirrhous gastric cancers
por: Hara, Toshifumi, et al.
Publicado: (2022)

A Novel Experimental Mouse Model of Peritoneal Dissemination of Human Gastric Cancer Cells: Different Mechanisms in Peritoneal Dissemination and Hematogenous Metastasis
por: Nishimori, Hidefumi, et al.
Publicado: (2000)

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
por: Williams, Eleanor, et al.
Publicado: (2021)

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023)

Importance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts
por: Harrach, Saliha, et al.
Publicado: (2017)

Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion
por: Yamaguchi, Hideki, et al.
Publicado: (2015)

A GSDMB enhancer-driven HSV thymidine kinase-expressing vector for controlling occult peritoneal dissemination of gastric cancer cells
por: Saeki, Norihisa, et al.
Publicado: (2015)

Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
por: Shin, Jin Soo, et al.
Publicado: (2018)

Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants
por: Thompson, Summer L., et al.
Publicado: (2021)

SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling
por: Nagamura, Yuko, et al.
Publicado: (2021)

Homeostatic membrane tension constrains cancer cell dissemination by counteracting BAR protein assembly
por: Tsujita, Kazuya, et al.
Publicado: (2021)

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer
por: McGivern, Niamh, et al.
Publicado: (2017)

PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines
por: Nakachi, I, et al.
Publicado: (2016)

Gut dysbiosis following organophosphate, diisopropylfluorophosphate (DFP), intoxication and saracatinib oral administration
por: Gage, Meghan, et al.
Publicado: (2022)

Development and Biological Analysis of a Novel Orthotopic Peritoneal Dissemination Mouse Model Generated Using a Pancreatic Ductal Adenocarcinoma Cell Line
por: Yanagihara, Kazuyoshi, et al.
Publicado: (2019)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
por: Heusschen, Roy, et al.
Publicado: (2016)

Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice
por: Luo, Xin-Ming, et al.
Publicado: (2021)

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
por: Kaye, S, et al.
Publicado: (2012)

Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
por: Lang, Liwei, et al.
Publicado: (2018)

Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma
por: Liao, Xia, et al.
Publicado: (2020)

Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo
por: Du, Guifang, et al.
Publicado: (2020)

Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
por: Sakamoto, Shuichi, et al.
Publicado: (2019)

Disseminated Peritoneal Leiomyomatosis
por: Momtahan, Mozhdeh, et al.
Publicado: (2011)

Integrated fluorescent cytology with nano‐biologics in peritoneally disseminated gastric cancer
por: Watanabe, Megumi, et al.
Publicado: (2018)

A Novel Experimental Mouse Model of Peritoneal Dissemination of Human Gastric Cancer Cells: Analysis of the Mechanism of Peritoneal Dissemination Using cDNA Macroarrays
por: Nomura, Hiroki, et al.
Publicado: (2001)

Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer
por: Jinno, Naruomi, et al.
Publicado: (2020)

The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
por: Kuwada, Kazuya, et al.
Publicado: (2018)

Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination
por: Kurashige, Junji, et al.
Publicado: (2016)

Genetic Defect in Phospholipase Cδ1 Protects Mice From Obesity by Regulating Thermogenesis and Adipogenesis
por: Hirata, Masayuki, et al.
Publicado: (2011)

Met in Urological Cancers
por: Miyata, Yasuyoshi, et al.
Publicado: (2014)

Disposition Kinetics of Taxanes in Peritoneal Dissemination
por: Miyamoto, Ken'ichi, et al.
Publicado: (2012)

Identification of zinc finger protein of the cerebellum 5 as a survival factor of prostate and colorectal cancer cells
por: Satow, Reiko, et al.
Publicado: (2017)

An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain
por: Danson, Sarah, et al.
Publicado: (2019)

Exploring the benefits of in-diet versus repeated oral dosing of saracatinib (AZD0530) in chronic studies: insights into pharmacokinetics and animal welfare
por: Vasanthi, Suraj S., et al.
Publicado: (2023)

Disseminated peritoneal leiomyomatosis: a rare cause of enigmatic peritoneal masses
por: Hiremath, Shivaprakash Basavanthaiah, et al.
Publicado: (2016)

Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis
por: Sakai, Norihiko, et al.
Publicado: (2017)

Favorable control of hepatocellular carcinoma with peritoneal dissemination by surgical resection using indocyanine green fluorescence imaging: a case report and review of the literature
por: Tani, Yuma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qrei1ndta35i36p811snnukkba